RxDoctor Payments DataLook up a doctor →

Mathias Bostrom, MD

Orthopaedic Surgery · White Plains, NYNPI 1952418659

Payments from drug & device makers

$2,073,364in general payments, 2019–2025

Across 407 payments — averaging $5094.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$2.1M
  • Radius Health, Inc.$11K
  • Stryker$12
$474in research payments, 2019–2025

Across 1 payment — averaging $474.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$474

What the payments were for

  • Royalty or licence$1,402,20268%
  • Consulting fees$353,80817%
  • Speaking & faculty fees$212,07710%
  • Travel & lodging$71,2533%
  • Food & beverage$13,0131%
  • Education$4,9770%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew374$2,062,769
Radius Health, Inc.32$10,582
Stryker1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,073,364 in reported general payments places this provider in the 95th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York

Medicare billing

Part B allowed, 2024
$329,315
Medicare patients
554
Services billed
1,640

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam74$259
Methylprednisolone36$237
Amoxicillin74$148
Clindamycin Hcl12$27

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in White Plains

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →